| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.44 | 0.03 |